Science Explorer Back to mapMap
Discussion
Researcher · Althaia · Spain

Sílvia Catot

Sílvia Catot publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment and Lung Cancer Research Studies.

ORCID 0000-0002-6918-7104 OpenAlex
World rank
#2,220,116
of 7,710,434 ranked researchers
Rank in Spain
#48,088
of 204,306
Works
36
Citations
3k
Citations per work
83.3
h-index
13
i10-index 14Top 38% in Pulmonary and Respiratory Medicine
Sílvia Catot

What does Sílvia Catot research?

Sílvia Catot's work is mostly in Medicine (66%), Biochemistry, Genetics and Molecular Biology (16%).

Health Sciences: 24 works · 66.4% of their workMedicine: 24 works · 66.4% of their workPulmonary and Respiratory Medicine: 12 works · 32.7% of their workOncology: 8 works · 22.8% of their workReproductive Medicine: 2 works · 5.9% of their workInfectious Diseases: 2 works · 5.0% of their workEverything else: 6 works · 17.8% of their workLife Sciences: 6 works · 15.8% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 15.8% of their workMolecular Biology: 3 works · 8.9% of their workCancer Research: 2 works · 6.9% of their workTHEIR WORKSílvia Catot36works
Life Sciences16%Health Sciences66%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine2466.4%
  2. Everything else617.8%
    1. Biochemistry, Genetics and Molecular Biology615.8%
  1. 1Pulmonary and Respiratory Medicine33% of their works
  2. 2Oncology23% of their works
  3. 3Molecular Biology9% of their works
  4. 4Cancer Research7% of their works
  5. 5Reproductive Medicine6% of their works
  6. 6Infectious Diseases5% of their works

Research topics

Which keywords describe Sílvia Catot's research?

The keywords of their largest research topics: Clinical Trials, Targeted Therapy, Chemotherapy, ALK Inhibitors, EGFR Mutations, Biomarkers, Metastasis and Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Clinical Trials243 topics
  2. Targeted Therapy233 topics
  3. Chemotherapy193 topics
  4. ALK Inhibitors131 topic
  5. EGFR Mutations131 topic
  6. Biomarkers112 topics
  7. Metastasis112 topics
  8. Immunotherapy102 topics
  9. CT Screening81 topic
  10. Lung Cancer81 topic
  11. Genomic Profiles61 topic
  12. Small-Cell Lung Cancer61 topic
  13. Genomic Analysis51 topic
  14. Ovarian Cancer51 topic
  15. BAP1 mutations41 topic
  16. Cancer Genomics41 topic
  17. Malignant Pleural Mesothelioma41 topic
  18. Mutational Signatures41 topic
  19. Coronavirus31 topic
  20. Immune Checkpoint Blockade31 topic
  21. PD-1 and PD-L131 topic
  22. SARS-CoV-231 topic

Where does Sílvia Catot work?

Sílvia Catot's main affiliation in the publication record is Althaia, Spain.

How many publications and citations does Sílvia Catot have?

OpenAlex counts 36 works and 2,997 citations for Sílvia Catot, an h-index of 13, ranking #2,220,116 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sílvia Catot. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.